Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dongjun Qin"'
Autor:
Fang Qiu, Yuntong Li, Lile Zhou, Yingli Wu, Yunzhao Wu, Zhilei Fan, Yingying Wang, Dongjun Qin, Chaoqun Li
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundOvarian cancer is a highly aggressive malignancy with limited therapeutic options and a poor prognosis. Deubiquitinating enzymes (DUBs) have emerged as critical regulators of protein ubiquitination and proteasomal degradation, influencing v
Externí odkaz:
https://doaj.org/article/20da6831785a49798bbf917f3526af96
Autor:
Yun Yu, Lili Song, Ying-Li Wu, Jian-Xin Pu, Hanzhang Xu, Li Xia, Wei Wei, Han-Dong Sun, Hu Lei, Dongjun Qin, Chuan-Xu Liu, Weiwei Wang, Siguo Hao
Publikováno v:
Molecular Medicine Reports. 13:2201-2207
Although 1,25‑dihydroxyvitamin D3 (VD3) is regarded as a promising inducing agent for leukemia cell differentiation, it is not as effective an agent as all‑trans‑retinoic acid, and its usefulness is also limited by the adverse effects of hyperc
Autor:
Ying-Li Wu, Dongjun Qin, Chunmin Ma, Li Xia, Wei Wei, Zhimin Huang, Feng-Hou Gao, Chuan-Xu Liu, Yun Yu, Jian Zhang, Min Huang, Hu Lei, Yang Cao, Yin Tong, Yingyi Chen, Hanzhang Xu, Tong-Dan Wang, Li Yang
Publikováno v:
Oncotarget
Identifying novel targets to enhance leukemia-cell differentiation is an urgent requirement. We have recently proposed that inhibiting the antioxidant enzyme peroxiredoxin I (Prdx I) may induce leukemia-cell differentiation. However, this concept rem
Autor:
Li Zhou, Bo Jing, Ying-Li Wu, Weiwei Wang, Haiyan Cai, Li Yang, Jin Jin, Jie-bo Chen, Meng Liu, Ze-xi Li, Xi Kou, Hu Lei, Dongjun Qin, Yunzhao Wu, Hanzhang Xu
Publikováno v:
Acta pharmacologica Sinica. 39(3)
Deubiquitinating protease USP7 is a promising therapeutic target for cancer treatment, and interest in developing USP7 inhibitors has greatly increased. In the present study, we reported a series of natural pentacyclic triterpenes with USP7 inhibitor
Autor:
Chunmin Ma, Haiyan Cai, Yunzhao Wu, Yingying Wang, Jinfu Zhang, Wei-Lie Xiao, Dongjun Qin, Weiwei Wang, Hu Lei, Hao Luo, Feng-Hou Gao, Jin Jin, Caixia Tang, Ying-Li Wu, Tong-Dan Wang, Hanzhang Xu
Publikováno v:
Oncotarget
// Dongjun Qin 1, * , Weiwei Wang 1, * , Hu Lei 1, * , Hao Luo 1, * , Haiyan Cai 1 , Caixia Tang 1 , Yunzhao Wu 1 , Yingying Wang 2 , Jin Jin 1 , Weilie Xiao 3 , Tongdan Wang 1 , Chunmin Ma 1 , Hanzhang Xu 1 , Jinfu Zhang 1 , Fenghou Gao 2 , Ying-Li
Autor:
Xiaochun Fei, Dongjun Qin, Sheng Liang, Li Biao, Hu Lei, Jiajia Hu, Hanzhang Xu, Ying-Li Wu, Yue Wang
Publikováno v:
Scientific Reports
The normal epithelial cell-specific-1 (NES1) gene, also named as KLK10, is recognised as a novel putative tumour suppressor in breast cancer, but few studies have focused on the function of KLK10 in human prostate cancer. Our study confirms that the
Autor:
WEI WEI, CHUANXU LIU, DONGJUN QIN, LILI SONG, LI XIA, HU LEI, YUN YU, WEIWEI WANG, JIANXIN PU, HANDONG SUN, YINGLI WU, HANZHANG XU, SIGUO HAO
Publikováno v:
Molecular Medicine Reports; 2016, Vol. 13 Issue 3, p2201-2207, 7p
Publikováno v:
2013 Third International Conference on Intelligent System Design & Engineering Applications; 1/ 1/2013, p1549-1553, 5p